Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?
Sep 23
Have your own idea? Try our Stock Screener
Indian (NIFTY) Clinical Research and Equipment Industry Analysis
UpdatedSep 25, 2025
DataAggregated Company Financials
Companies20
- 7D-2.0%
- 3M-6.1%
- 1Y1.3%
- YTDn/a
Last week, the Clinical Research and Equipment industry hasn't moved much but Dishman Carbogen Amcis is up 15% in that time. In line with that, the industry has also been flat over the past 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Sep 2025 | ₹3.1t | ₹331.4b | ₹45.5b | 45.3x | 69x | 9.5x |
| Sun, 24 Aug 2025 | ₹3.2t | ₹331.4b | ₹45.5b | 40.9x | 70.6x | 9.7x |
| Tue, 22 Jul 2025 | ₹3.3t | ₹319.5b | ₹41.7b | 53.8x | 79.4x | 10.4x |
| Thu, 19 Jun 2025 | ₹2.8t | ₹299.7b | ₹37.2b | 46.7x | 76.5x | 9.5x |
| Sat, 17 May 2025 | ₹2.7t | ₹294.5b | ₹32.8b | 49.8x | 82.7x | 9.2x |
| Mon, 14 Apr 2025 | ₹2.5t | ₹287.4b | ₹30.8b | 43.3x | 80.3x | 8.6x |
| Wed, 12 Mar 2025 | ₹2.5t | ₹287.4b | ₹30.8b | 48x | 80.1x | 8.6x |
| Fri, 07 Feb 2025 | ₹2.7t | ₹286.4b | ₹31.3b | 46.6x | 86.4x | 9.4x |
| Sun, 05 Jan 2025 | ₹2.6t | ₹269.1b | ₹30.1b | 55.4x | 85.9x | 9.6x |
| Tue, 03 Dec 2024 | ₹2.5t | ₹254.2b | ₹28.8b | 54.4x | 87.4x | 9.9x |
| Thu, 31 Oct 2024 | ₹2.4t | ₹247.9b | ₹26.0b | 49.4x | 91.5x | 9.6x |
| Sat, 28 Sep 2024 | ₹2.3t | ₹247.6b | ₹26.3b | 49.6x | 86.7x | 9.2x |
| Mon, 26 Aug 2024 | ₹2.1t | ₹247.1b | ₹23.8b | 38.2x | 87.9x | 8.5x |
| Wed, 24 Jul 2024 | ₹1.8t | ₹201.9b | ₹23.9b | 37.5x | 75x | 8.9x |
| Fri, 21 Jun 2024 | ₹1.7t | ₹194.5b | ₹21.5b | 33.8x | 81x | 9x |
| Sun, 19 May 2024 | ₹1.6t | ₹193.9b | ₹21.6b | 34.7x | 73x | 8.1x |
| Tue, 16 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 29.1x | 76x | 8.4x |
| Thu, 14 Mar 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 28.2x | 70.8x | 7.8x |
| Sat, 10 Feb 2024 | ₹1.4t | ₹167.1b | ₹19.0b | 33.1x | 74x | 8.4x |
| Mon, 08 Jan 2024 | ₹1.5t | ₹155.9b | ₹18.1b | 23.8x | 80.8x | 9.4x |
| Wed, 06 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.5x | 76.2x | 8.8x |
| Fri, 03 Nov 2023 | ₹1.2t | ₹156.0b | ₹19.8b | 23.4x | 63.2x | 8x |
| Sun, 01 Oct 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.4x | 71.8x | 9.1x |
| Tue, 29 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 27.4x | 69.3x | 8.8x |
| Thu, 27 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 30.9x | 59.6x | 8.8x |
| Sat, 24 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28.5x | 56.2x | 8.2x |
| Mon, 22 May 2023 | ₹1.2t | ₹160.8b | ₹22.9b | 32.9x | 51.6x | 7.3x |
| Wed, 19 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 33.5x | 42.1x | 7.5x |
| Fri, 17 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31x | 37x | 6.6x |
| Sun, 12 Feb 2023 | ₹1.1t | ₹159.6b | ₹28.5b | 34.2x | 37x | 6.6x |
| Tue, 10 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.7x | 36x | 7.5x |
| Thu, 08 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30.1x | 35.1x | 7.3x |
| Sat, 05 Nov 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 37.4x | 36.9x | 8.1x |
| Mon, 03 Oct 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.2x | 36.2x | 8x |
Price to Earnings Ratio
36.2x
Current Industry PE
- Investors are relatively neutral on the Indian Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 67.5x.
- The 3-year average PS ratio of 8.6x is lower than the industry's current PS ratio of 9.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 8.4% per year over the last three years.
- Revenues for these companies have grown 27% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Clinical Research and Equipment compare with similar industries?
| IN Market | -0.91% | |
| Healthcare | -0.97% | |
| Life Sciences | -2.00% | |
| Clinical Research and Equipment | -2.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DCAL Dishman Carbogen Amcis | ₹295.30 | 3.1% +₹1.4b | 61.4% | PE44.4x | |
| 530239 Suven Life Sciences | ₹219.35 | 0.2% +₹102.4m | 55.5% | PS663.8x | |
| 539267 Samsrita Labs | ₹19.99 | 2.5% +₹11.1m | -28.5% | PB3.8x |
